Biotech Values

[reddymade]

AH HGSI going high on CNBC by Mark Schoenebaum

Mark Schoenebaum is a respected Biotech analyst. He tells it like it is and has no agenda.

I was disappointed that he was seeing a 30% raise over the next 6 months. That is only a $7 increase over the current price.

When they asked him about buyouts I think he may have believed it would happen but it sounded more like he was hedging.

He did say that in all the years he has been an analyst that he has never seen a panel recommend a stock with a such a high vote (13-2) and see the stock go down. It surprised him. If you read between the lines I think he believes HGSI will go up and soon.